NCT00423839View on ClinicalTrials.gov

A Phase I Study of the Safety and Immunogenicity of MVA85A in Healthy Gambian Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 31, 2003

Study Completion Date

July 31, 2005

Conditions
Tuberculosis
Interventions
BIOLOGICAL

MVA85A (Tuberculosis vaccine)

Trial Locations (1)

Unknown

MRC Labs, Fajara

All Listed Sponsors
lead

University of Oxford

OTHER

NCT00423839 - A Phase I Study of the Safety and Immunogenicity of MVA85A in Healthy Gambian Volunteers | Biotech Hunter | Biotech Hunter